SciELO - Scientific Electronic Library Online

 
vol.43 issue1Cost/effectiveness evaluation of three fixed combinations of acetaminophen and opioids in the management of acute pain in ColombiaIntrathecal opioids and respiratory depression: Is it myth in obstetrics? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Colombian Journal of Anestesiology

Print version ISSN 0120-3347

Rev. colomb. anestesiol. vol.43 no.1 Bogotá Jan./Mar. 2015

 

Review

Liquid handling, lidocaine and epinephrine in liposuction. The properly form

Manejo de líquidos, lidocaína y epinefrina en liposucción. La forma correcta

Jorge Enrique Bayter Marin

MD, Anesthesiologist and Intensivist, Medical Director Clínica El Pinar, Bucaramanga, Colombia. Anesthesia for Plastic Surgery Coordinating Committee, Sociedad Colombiana de Antesiología y Reanimación (S.C.A.R.E.), Sociedad Colombiana de Anestesiología y Reanimación (S.C.A.R.E.) Bogotá, Colombia

E-mail address jokibay@yahoo.com

Article info
Article history: Received 28 April 2014 Accepted 13 September 2014


Abstract

Keywords: Lipectomy Pulmonary edema Anesthetics, local Toxicity Surgery, plastic

Introduction: Fluid mismanagement in liposuction leads to pulmonary edema in a previously healthy individual. Pulmonary edema is considered the third cause of death in plastic surgery after PTE and lidocaine toxicity. The most important risk factor leading to this outcome is inadequate knowledge of fluid management and poor communication between the surgeon and the anaesthetist.

Objectives: To review the causes leading up to pulmonary edema in liposuction and the valid options for correct fluid management.

Methods: Non-systematic review of the literature in PubMed and Medline.

Results and conclusions: Correct fluid management in liposuction is based on a close communication between the surgeon and the anaesthetist in order to keep track of the total amount of subcutaneous fluid infiltration plus fluids delivered intravenously, always bearing in mind that infiltration fluids go to the central circulation.

Keywords: Lipectomy, Pulmonary edema, Anesthetics, local, Toxicity, Surgery, plastic.


Resumen

Introducción: El mal manejo de líquidos en liposucción, conlleva a edema pulmonar en un paciente previamente sano. El edema pulmonar se considera la tercera causa de muerte en cirugía plástica después del TEP y la Intoxicación por lidocaína. El principal factor de riesgo que conlleva a este desenlace es el desconocimiento en el manejo de líquidos y la mala comunicación entre el cirujano y el anestesiólogo.

Objetivos: Revisar las causas que llevan a edema pulmonar en liposucción y las opciones validas de manejo correcto de líquidos.

Métodos: Se realizó una revisión de la literatura no sistemática en las bases de datos PubMed y Medline.

Resultados y conclusiones: El correcto manejo de líquidos en liposucción se basa en una estrecha comunicación entre el cirujano y el anestesiólogo para sumar los líquidos infiltrados a nivel subcutáneo y los colocados por vía venosa, siempre teniendo en cuenta que los líquidos de la infiltración pasan a la circulación central.

Palabras clave: Lipiectomía, Edema Pulmonar, Anestésicos locales, Toxicidad, Cirugía plásticar.


Introduction

Liposuction is the most common cosmetic surgery procedure performed in the United States1 and also in Colombia. Advances in the techniques for infiltration, designed to allow placement of epinephrine in a solution, thus reducing bleeding during lipoaspiration, have enabled removal in large volumes during liposuction. This induces significant changes in fluid behaviour inside the compartment, with the risk of pulmonary oedema and heart failure.2

Added to the invention by Klein in 1987 of a tumescent solution that included 500-1000 mg of lidocaine plus 1mg of epinephrine for every 1000 cc of NSS3 (Fig. 1) and which is widely used today for subcutaneous infiltration, the risk of lidocaine toxicity is a reality and the second cause of death in plastic surgery according to the American Society of Plastic Surgeons (ASPS).

The biggest problem with these new infiltration techniques, in particular the super wet and the tumescent techniques is associated with the large infiltration volumes, at infiltration/aspiration ratios ranging from 1:1 in the super wet technique up to 2-3:1 in the tumescent technique.4 This means that in a 3-litre liposuction, subcutaneous fluid infiltration may amount to 3-9 litres, and this fluid volume requires special consideration from the point of view of anaesthesia.

Methods

Non-systematic review of the literature using the PubMed and Medline databases, introducing key words in English like Fluid Management, Liposuction, pulmonary oedema, larger infiltration, Aspiration volumes. All the articles were read and other articles of the selected references regarding the topic were also queried. Overall, 151 references were selected using this methodology.

Review

The use of large infiltration volumes in the tumescent solutions increases the difficulty of anaesthetic management in liposuction significantly. The risk of hypervolemia, pulmonary oedema, epinephrine-related cardiovascular effects, and lido-caine toxicity is always present.5

The purpose of using infiltration solutions with 1mg of epinephrine in 1000 cc of Hartman's or NSS is to reduce bleeding into the lipoaspirate down to less than 5% of the extracted volume.6 This results in the ability to perform large-volume liposuction, with the ensuing complications. Some studies conducted by Burk and Vasconez7 have shown the use of up to 10 mg of epinephrine at concentrations of 1:1,000,000 in healthy patients, with no deleterious effects from toxicity such as tachycardia and hypertension, although these megadoses may lead to fatal consequences in patients with underlying cardiac disease in whom no workup has been done.

The second problem, when Klein solutions are used, is the infiltration of high doses of lidocaine (500-1000 mg of 1% lido-caine for every 1000 cc of NSS). There are multiple studies in the world literature conducted in plastic surgery patients that show that very high doses of lidocaine (up to 35-55 mg/kg) could be safe8,9 considering that the infiltration is applied to scarcely vascularized adipose tissue and, moreover, considering the additional vasoconstriction derived from the use of epinephrine in the dilution. These studies have shown a margin of safety in thousands of liposuction procedures performed, with no risk of toxic levels despite the high doses of infiltrated lidocaine.

As far as anaesthesia is concerned, the FDA only accepts maximum doses of 7-10 mg/kg. The ASPS has reported that lidocaine toxicity may be an important cause of death in plastic surgery and might account for some intra- and postoperative deaths resulting from cardiac arrest in conditions of normal oxygen saturation. However, this is very difficult to demonstrate because of the difficulty in measuring postmortem serum levels, something that is usually done late or not done at all. It is worth noting that the use of high lidocaine doses has enabled dermatologists and surgeons to perform liposuction in their offices using local anaesthesia without the support of an anaesthetist, with the sole purpose of lowering the costs associated with the use of the operating room and the support of the anaesthetist. For this reason, our recommendation, when large quantities of lidocaine are used for infiltration, is that an anaesthetist must be present in the room and must be prepared to manage lidocaine toxicity-related cardiac arrest. Additionally, 20% lipids must be available in the room as the only effective measure to revert cardiac arrest while waiting for resuscitation. Fig. 2, shows the protocol for the management of local anaesthetic toxicity-related cardiac arrest, endorsed by the American Society of Regional Anaesthesia and the American Society of Plastic Surgeons, and published in http://www.lipidrescue.org together with the supporting literature.

The third issue relates to the large volumes of infiltrated fluids and volume overloading: in a 4-litre liposuction, subcutaneous fluid infiltration may be as high as 12 litres.

In1998, the UniversityofTexas Southwestern MedicalCen-tre defined that a large-volume liposuction is the removal of more than 4000 cc of fat, while a small-volume liposuction corresponds to the removal of less than 4000 cc. The same study determined that the volume of fluids delivered is equal to the volume of infiltration fluids given by the plastic surgeon plus the volume of intravenous fluids given by the anaesthetist. When added together and then divided by the liposuction volume, the ratio should not be greater than 2 for liposuctions under 4L (or 8 litres of fluids administered when intravenous and infiltration fluids are added together, in a 4-litre liposuction), or greater than 1.4 for liposuctions of more than 4 litres. In this study of 53 patients there were no cases of complications or fluid overload, and diuresis was maintained at a level higher than 1 cc/k/h. In a later study by Rohrich in 89 patients,10 it was shown, in essence, that the use of this same formula for liposuction does not result in complications.

In plastic surgery, pulmonary oedema is the third cause of death, resulting mainly from human error associated with the lack of knowledge of the basic physiological principles of infiltration, the lack of protocols, and poor communication between the surgeon and the anaesthetist. In a study conducted in The Netherlands in 50% of the hospitals between 1995 and 1997, it was found that 2-4% of all anaesthesia-related deaths were due to poor fluid management and pulmonary oedema, and medical error was demonstrated in 85% of these fatal cases.11

The main physiological consideration is that most of the infiltrated fluids go into the general circulation and only 22-29% is recovered with lipoaspiration.12,13 This means that up to 70% of infiltration fluids, lidocaine and epinephrine go into the intravascular space. Later studies have shown that 1 litre of subcutaneous infiltration is fully resorbed if not removed within 163 min, and that 70% of the lidocaine and epinephrine is totally resorbed, with maximum peaks at 12 and 5 h.4

In a study of 5 healthy ASA 1 women14 undergoing large-volume liposuction, a Swan-Ganz catheter was used for 24-h monitoring in the ICU, with continuous measurement of the haemodynamic parameters in order to assess the effects of the infiltration and the high adrenaline doses. It was determined that cardiac index, heart rate and mean pulmonary artery pressure increased by more than 45%, while central venous pressure increased from 4 to 14cm H2O 8h into the postoperative period.14 Moreover, the same study showed that all patients were hypothermic during surgery with recorded temperatures under 35.5 °C.

High doses of epinephrine are used routinely in liposuc-tion, with all the haemodynamic implications. Epinephrine reaches maximum concentration levels 3-5 h after subcutaneous administration. After infiltrating 7mg of adrenaline, serum levels reach 323 pg/ml, very similar to the levels found in aortic clamping or coronary bypass,15,7 which are 3 or 4 times as high as baseline levels. In fact, there are anecdotal reports on epinephrine-related complications in patients with previously undiagnosed coronary heart disease; this is due to the low rate of its systemic absorption in fat and to its vasocon-striction effect, and the potential protective anti-arrhythmic effect of lidocaine.7

The presence of lidocaine in the infiltration may lead to serious and even fatal complications. Neurological symptoms appear when levels are above 5 xg/cc, and there is cardiovascular collapse with levels higher than 10 xg/cc.16 Apparently, many studies have shown a certain margin of safety with subcutaneous lidocaine infiltration, even in doses as high as 55 mg/kg, due to the low vascularity of fat and the vasoconstrictor effect of adrenaline.17-19 The problem is that its release from fat is also slow, and it has been shown that maximum levels are reached within 8-12 h after the infiltration20 when the patient is already at home, creating an additional risk. It is also important to take into consideration differential absorption rates, given that when the face is infiltrated, maximum concentrations are reached after 5 h, but when the abdomen and the thighs are infiltrated, they peak at 12 h, and at some point there may be a summation effect.18 Lidocaine metabolism may worsen the situation in cases of toxicity. Lidocaine is cleared mainly through liver metabolism (95%) while only 5% is cleared through the urine.21 It is deacetylated to monoethyliglycinexylidine (MEGX) which is then deacetylated to glycinexylidine (GX). The two enzymes responsible for this action are CYP3A4 and CYP1A2 which belong to the cytochrome P450 family of isoenzymes.21,22 These isoenzymes may be inhibited by various commonly used drugs, including ciprofloxacin, cimetidine, erythromycin, amiodarone, ketoconazole, fluconazole and even propofol;21,22 or the metabolism may be altered by drugs that compete for the same enzyme, as is the case of midazolam and fen-tanyl, which are also metabolized by CYP3A4.21,22 This is very important because these drugs not only may alter the metabolism but also may mask the initial signs of intoxication, leading to serious neurological or cardiovascular symptoms. Although these subcutaneous megadoses of 35-50 mg/kg of lidocaine may seem suboptimal, intraoperative deaths have been reported due to heart block in conditions of normal oxygen saturation. In those cases, the autopsy does not find any abnormality,23 and lidocaine levels may appear normal; however post-mortem stability of lidocaine has not been demonstrated so far. In a census carried out among all the members of the American Society of Plastic Surgeons in 2000, mortality from liposuction was shown to be 1 out of every 5000 procedures. The primary cause of death was PTE, but it was also found that most deaths occurred on the first postoperative night, so lidocaine toxicity and residual anaesthetic effects are not ruled out as an important cause of mortality.

Although PTE is the main cause of death, there are stringent, well developed protocols for prophylaxis that may lower the incidence of DVT and PTE by 85%, and of fatal PTE by 95%. The problem with fluid management in liposuction is that with the new super wet and tumescent infiltration techniques, fluid overload is a potential risk and there is no consensus regarding its management to this date. There are only a few empirical division formulae for fluid delivery versus infiltration fluids to guide the management of fluid therapy.24-26 Using these formulae, fluid delivery in a liposuction under 4 litres must follow a ratio of 2 between infiltrated plus intravenous fluids divided by the aspirate, and a ratio of 1.4 in a liposuction of more than 4 litres.24-26 Despite these formulae, fluid overload continues to be a problem, and there are reports of deaths in liposuction when they are applied. Intravenous fluids are being used less in liposuction, and although the standard is not to use the tumescent technique (3:1) but the super wet technique (1:1), this has contributed to a lowering of fluid delivery down to a ratio of 1.2 between fluids delivered (intravenous plus infiltration) and fat removed, according to Rohrich.24 Recently, a study was conducted with 30 patients undergoing large volume liposuctions of more than 6 litres in which half of the patients received fluids according to Rohrich, i.e. a 1.2 ratio (for a 6-litre liposuction they could receive only a maximum of 7200 cc of infiltrated plus intravenous fluids) and the other half of the patients received fluids on the basis of systolic volume variation using the arterial line ther-modilution technique (LIDCO).27 This study showed that, in large-volume liposuction where infiltration was greater than 1:1, intravenous fluids were used only for maintenance -500 to 600 cc over the 5 h of surgery - and an excellent stroke volume was achieved, with diuresis remaining always above 1.2cc/k/h.27-29 Studies show that intravenous fluid quantities must be as low as possible when super wet techniques are used30,31 (Table 1), and there are some that have even proposed abolishing intravenous fluids.32 In conclusion, when liposuction is performed as a single procedure, conservative management of intravenous fluids is required, considering that infiltration fluids go into the central circulation. Consequently, the recommendation is to use only maintenance fluids.

As stated above, fluid management also involves managing infiltration, lidocaine and epinephrine levels, and hypothermia.33 Together, these factors are responsible for numerous reports of deaths due to myocardial infarction, pulmonary oedema and lidocaine toxicity.33-43.

Although it is not within the scope of this paper, it needs to be mentioned that the subcutaneous infusion of these large volumes of infiltration fluids at ambient temperature means that temperature in all patients remains under 36°C. Consequently, we are required to take the necessary steps to avoid hypothermia, considering that it may lead to problems such as bleeding, AMI and seromas.44-47

Conclusions

Correct fluid and infiltration management, together with the steps for preventing DVT and PTE, is the most important measure to reduce complications and deaths in plastic surgery. Regarding fluid management in liposuction, when super wet or tumescent techniques are used, the worldwide recommendation is to use a minimum amount of intravenous fluids, that is, only maintenance fluids, because the infiltrated volume is sufficient (1.2 maximum ratio between fluid delivery and fat removal).

As for the dose of epinephrine in the infiltration, it should not be higher than 6 mg or 1 kg/kg, as long as the patient does not have an underlying cardiovascular disease.

As for lidocaine, although the FDA recommends a maximum of 7-10 mg/kg, there are multiple studies showing that higher doses (35 mg/kg) are relatively safe. Consequently, in cases of infiltration with large volumes of lidocaine, our recommendation is that the procedure must be performed under the constant supervision of an anaesthetist who must be prepared to manage lidocaine toxicity-related cardiac arrest. Moreover, 20% lipids must be available in the room as the sole effective measure to revert cardiac arrest while waiting for resuscitation.

Financing

No.

Conflicts of interest

The author is coordinator of the Committee on Anesthesia for Plastic Surgery, Sociedad Colombiana de Anestesiología y Reanimación (S.C.A.R.E.).


References

1. Rohrich RJ, Beran SJ, Fodor PB. The role of subcutaneous infiltration in suction-assisted lipoplasty: a review. Plast Reconstr Surg. 1996;9:514.         [ Links ]

2. Grazer FM, Meister FL. Factors contributing to adverse effects of the tumescent technique (surgical strategies). Aesthetic Surg J. 1997;7:411-6.         [ Links ]

3. Klein JA. The tumescent technique for liposuction surgery. Am J Cosmetic Surg. 1987;4:263-6.         [ Links ]

4. Trott SA, Beran SJ, Rohrich RJ, Kenkel JM, Adams WP, Klein KW. Safety considerations and fluid resuscitation in liposuction: an analysis of 53 consecutive patients. Plast Reconstr Surg. 1998;102:2220-5.         [ Links ]

5. Burk RW, Guzman-Stein G, Vasconez LO. Lidocaine and epinephrine levels in tumescent technique liposuction. Plast Reconstr Surg. 1996;97:1379-85.         [ Links ]

6. Klein JA. Tumescent technique for local anesthesia improves safety in large-volume liposuction. Plast Reconstr Surg. 1993;92:1085-90.         [ Links ]

7. Burk RW, Guzman-Stein G, Vasconez LO. Lidocaine and epinephrine levels in tumescent technique liposuction. Plast Reconstr Surg. 1996;97:1379-84.         [ Links ]

8. Klein JA. Tumescent technique for regional anesthesia permits lidocaine doses of 35 mg/kg for liposuction. J Dermatol Surg Oncol. 1990;16:248-52.         [ Links ]

9. Ostad A, Kageyama N, Moy R. Tumescent anesthesia with a lidocaine dose of 55 mg/kg is safe for liposuction. Dermatol Surg. 1996;22:921-8.         [ Links ]

10. Rohrich RJ, Jason E, Leedy, Swamy JR. Fluid resuscitation in liposuction: a retrospective review of 89 consecutive patients. Plast Reconstr Surg. 2006;117:431-6.         [ Links ]

11. Arbous MS, Grobbee DE, van Kleef JW. Mortality associated with anaesthesia: a qualitative analysis to identify risk factors. Anaesthesia. 2001;56:1141-53.         [ Links ]

12. Samdal F, Amland PF, Bugge JF. Blood loss during liposuction using the tumescent technique. Aesthetic Plast Surg. 1994;18:157-62.         [ Links ]

13. Pitman GH, Aker JS, Tripp ZD. Tumescent liposuction. Clin Plast Surg. 1996;23:633-8.         [ Links ]

14. Kenkel JM, Lipschitz AH, Luby M, Kallmeyer I. Hemodynamic physiology and thermoregulation in liposuction. Plast Reconstr Surg. 2004;114:503-13.         [ Links ]

15. Brown SA, Lipschitz AH, Kenkel JM, et al. Pharmacokinetics and safety of epinephrine use in liposuction. Plast Reconstr Surg. 2004;114:756-65.         [ Links ]

16. Rubin JP, Zhongcong X, Davidson Ch, et al. Rapid absorption of tumescent lidocaine above the clavicles: a prospective clinical study. Plast Reconstr Surg. 2005;115:1744-51.         [ Links ]

17. Feisher LA. Risk of anesthesia. In: Miller RD, editor. Anesthesia. Churchill Livingstone; 2005. p. 893-920.         [ Links ]

18. Hughes CE. Reduction of lipoplasty risks and mortality: an ASAPS survey. Ann Plast Surg. 2001;21:120-7.         [ Links ]

19. Butterwick KJ, Goldman MP, Sriprachya-Anunt S. Lidocaine levels during the first two hours of infiltration of dilute anesthetic solution for tumescent liposuction: rapid versus slow delivery. Dermatol Surg. 1999;25:681-5.         [ Links ]

20. Sweeney BP, Bromilow J. Liver enzyme induction and inhibition: implications for anaesthesia. Anaesthesia. 2006;61:159-77.         [ Links ]

21. Rao RB, Ely SF, Hoffman RS. Deaths related to liposuction. N Engl J Med. 1999;340:1471-5.         [ Links ]

22. Rohrich RJ, Kenkel JM, Jani JE, Beran SJ, Fodor PB. An update on the role of subcutaneous infiltration in suction-assisted lipoplasty. Plast Reconstr Surg. 2003;111:926-7, discussion 928.         [ Links ]

23. Basile AR, Fernandes F, Basile VV, Basile FV. Fluid resuscitation in liposuction: a prospective analysis of infiltrate total-aspirate ratios lower than used for the super wet technique. Aesthetic Plast Surg. 2006;30:659-65, discussion 666.         [ Links ]

24. Trott SA, Beran SJ, Rohrich RJ, Kenkel JM, Adams WP Jr, Klein KW. Safety considerations and fluid resuscitation in liposuction: an analysis of 53 consecutive patients. Plast Reconstr Surg. 1998;102:2220-9.         [ Links ]

25. Jain AK, Khan AM, Asma MM. Stroke volume variation as a guide for fluid resuscitation in patients undergoing large-volume liposuction. Plast Reconstr Surg. 2012;130:462-9.         [ Links ]

26. Reuter DA, Felbinger TW, Kilger E, Schmidt C, Lamm P, Goetz AE. Optimizing fluid therapy in mechanically ventilated patients after cardiac surgery by on-line monitoring of left ventricular stroke volume variations: a comparison to aortic systolic pressure variations. Br J Anaesth. 2002;88:124-6.         [ Links ]

27. Reuter DA, Kirchner A, Felbinger TW, et al. Usefulness of left ventricular stroke volume variation to assess fluid responsiveness in patients with reduced cardiac function. Crit Care Med. 2003;31:1399-404.         [ Links ]

28. de Jong RH, Grazer FM. Perioperative management of cosmetic liposuction. Plast Reconstr Surg. 2011;107:1039-44.         [ Links ]

29. Pitman GH, Aker JS, Tripp ZD. Tumescent liposuction: a surgeon's perspective. Clin Plast Surg. 1996;23:633-41.         [ Links ]

30. Sasaki GH, Tevez A. Larger infiltration/aspiration volumes, plasma/subcutaneous fluid lidocaine levels and quantitative abdominal tissue accommodation after water-assisted liposuction (WAL): comparative safety and efficacy to traditional liposuction (TL) in advanced techniques in liposuction and fat transfer. 11th ed; 2011. p. 81-94.         [ Links ]

31. Grazer FM, de Jong RH. Fatal outcomes from liposuction: census survey of cosmetic surgeons. Plast Reconstr Surg. 2000;105:436-42.         [ Links ]

32. Barillo DJ, Cancio LC, Kim SH, et al. Fatal and near fatal complications of liposuction. South Med J. 1998;91:487-94.         [ Links ]

33. Gorney M. Suction-assisted lipoplasty: complications and fatal outcomes. In: Presented at the annual meeting of the American Society of Plastic and Reconstructive Surgeons. 1998.         [ Links ]

34. Gingrass MG. Lipoplasty complications and their prevention. Clin Plast Surg. 1999;26:341-9.         [ Links ]

35. de Jong RH, Grazer FM. Tumescent liposuction alert: deaths from lidocaine cardiotoxicity. Am J Forensic Med Pathol. 1999;20:100-7.         [ Links ]

36. Platt MS, Kohler LJ, Ruiz R, et al. Deaths associated with liposuction: case reports and review of the literature. J Forensic Sci. 2002;47:205-9.         [ Links ]

37. American Society of Plastic Surgeons. Procedural Statistics Report. Arlington Heights Ill. American Society of Plastic Surgeons; 2001.         [ Links ]

38. Klein JA. The tumescent technique: anesthesia and modified liposuction technique. Dermatol Clin. 1990;8:425-32.         [ Links ]

39. Samdal F, Amland PF, Bugge JF. Blood loss during liposuction using the tumescent technique. Aesthetic Plast Surg. 1994;18:157-63.         [ Links ]

40. Lillis PJ. Liposuction surgery under local anesthesia: limited blood loss and minimal lidocaine absorption. J Dermatol Surg Oncol. 1988;14:1145-52.         [ Links ]

41. Iverson RE. Patient safety in office-based surgery facilities: 1. Procedures in the office-based surgery setting. Plast Reconstr Surg. 2002;110:1337-45.         [ Links ]

42. Sessler DI. Perioperative heat balance. Anesthesiology. 2000;92:578-84.         [ Links ]

43. Yamakage MY, Kamada Y, Homma Y, Tsujiguchi N, Namiki A. Predictive variables of hypothermia in the early phase of general anesthesia. Anesth Analg. 2000;90:456-63.         [ Links ]

44. Alfonsi P. Postanesthetic shivering: epidemiology, pathophysiology, and approaches to prevention and management. Drugs. 2001;61:2193-9.         [ Links ]

45. Scheeren TW. Relation between oxygen consumption and cardiac output during inhalation anesthesia under the influence of catecholamines: a study in dogs. Anasthesiol Intensivmed Notfallmed Schmerzther. 2000;35:214-22.         [ Links ]

46. Hoffman BB. Catecholamines, sympathomimetic drugs and adrenergic receptors antagonists. In: Hardman JG, Limbird LE, Gilman AG, editors. The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 215-68.         [ Links ]

47. Cheung PY, Barrington KJ. The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets. Crit Care. 2001;5:158-65.         [ Links ]